This study was published in Clinical Therapeutics 2008 Mar;30(3):535-42
Study title and authors
The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Study title and authors
The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE, Sowell MO, Stender M, Qizilbash N.
Worldwide Epidemiology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, USA. carol.e.koro@gsk.com
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/18405791
Worldwide Epidemiology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, USA. carol.e.koro@gsk.com
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/18405791
This study investigated the association of statins and various antidiabetic drugs with the risk of myopathy (muscle disease) in patients with type two diabetes. The study included 3,696 patients with myopathy who were matched with 21,871 controls.
The study found that compared with patients who did not use either statins nor antidiabetic drugs, those who used statins had a 36% increased risk of muscle disease.
No comments:
Post a Comment